Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation.
A 56-year-old man was diagnosed with Mycobacterium genavense duodenitis 21 months after an allogeneic peripheral stem cell transplant complicated by graft-versus-host disease requiring intense immunosuppression. This duodenitis responded to prolonged therapy with clarithromycin, ciprofloxacin, and rifabutin and reduction of immunosuppression.
Lu
K J
KJ
Victorian Infectious Disease Service and Center for Clinical Research Excellence in Infectious Disease, The Royal Melbourne Hospital, Victoria, Australia. ken.lu@austin.org.au
Grigg
A
A
Leslie
D
D
Finlay
M
M
Sasadeusz
J
J
D004382:Duodenitis / Q000382:microbiology*; D006086:Graft vs Host Disease / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D009161:Mycobacterium / Q000145:classification / Q000235:genetics / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000382:microbiology*; D009894:Opportunistic Infections / Q000382:microbiology*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D016133:Polymerase Chain Reaction / Q000379:methods; D014184:Transplantation, Homologous / Q000009:adverse effects*